As of Sep 13
| -1.61 / -0.86%|
The 6 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 240.00, with a high estimate of 255.00 and a low estimate of 215.00. The median estimate represents a +28.75% increase from the last price of 186.41.
The current consensus among 9 polled investment analysts is to Buy stock in Abiomed Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.